Vascular Improvement With Olmesartan Medoxomil Study
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare in patients with primary hypertension, the non-blood
pressure lowering effects of one-year therapy with olmesartan medoxomil vs. those of atenolol
on changes in the vascular structure and function.